Featured
Research
How can pharma get the few promising drugs in development to patients battling superbugs?
23 May 2024
Martijn van Gerven to share Foundation’s work on AMR at Global AMR R&D Hub Annual Stakeholder Group Meeting
The Access to Medicine Foundation’s Research Programme Manager, Martijn van Gerven, will be attending the AMR R&D Hub’s Annual Stakeholder Group Meeting, where he will share insights from the Foundation’s work on antimicrobial resistance (AMR).
Date
26 November 2024
Location
Berlin, Germany
As a member of the Global AMR R&D Hub, Foundation has been invited to participate in the Annual Stakeholder Group Meeting on 26 November, 2024. The event will bring together executives, industry experts, and global health leaders committed to addressing antimicrobial resistance. Martijn van Gerven, the Foundation’s Research Programme Manager for its AMR programme, will attend the meeting in Berlin.
Martijn will draw from the Foundation’s work in its AMR Programme, including highlights from the recently published research and development (R&D) paper, which focuses on how companies can improve access and stewardship planning to ensure newly developed antibiotics and antifungals reach patients who need them the most.
He will also share key takeaways from the Foundation's Expert Review Committee meeting on 17 October, where new proposals for changes to the AMR programme’s methodology framework were introduced to better assess companies' efforts to combat drug resistance. Representatives from pharmaceutical companies in attendance will find this particularly useful in gaining insights on access and stewardship planning in low-and middle-income countries (LMICs).
About the AMR R&D Hub
The Global AMR R&D Hub is a partnership of countries, non-governmental donor organisations and intergovernmental organisations to address challenges and improve coordination and collaboration in global AMR R&D using a One Health approach.
